This dissertation investigates the structure of incentive contracts in which adverse selection problems are more severe. Specifically, I examine the moderating effect of R&D intensity on the relative weights placed on signals of ability and on performance measures in executive compensation. Furthermore, I also investigate the determinants on the compensation of university presidents. I find that that more weight is placed on signals of ability in R&D intensive firms and less weight is placed on performance measures. I find that R&D intensive firms pay more to executives with technical work experience and/or relevant educational degrees. Additionally, in the context of university presidents, the positive association between organizational complexity and executive compensation is driven by the role of managerial ability rather than by effort. This result also suggests that considering measures of organizational complexity (such as firm size and diversification) as control variables in empirical studies of executive compensation is the appropriate means by which to account for the impact of organizational complexity. / Business Administration/Accounting

El propósito de esta tesis es triple e intenta comprender un importante resultado de la innovación organizativa: la innovación de proceso. Primero, el artículo aborda un tema en emergente crecimiento: la importancia de los innovadores no-I+D (innovadores sin I+D que innovan). Segundo, el artículo explora y arroja luz sobre el fenómeno de la innovación de proceso que ha recibido menos atención por parte de los académicos en los últimos años, más centrados en el fenómeno de la innovación de producto. En tercer lugar, el artículo también busca ideas para determinar el grado en que las actividades de innovación de proceso son interdependientes de la innovación de producto. La tesis constituye un intento de obtener una fértil síntesis de los estímulos de la innovación de proceso y sus resultados usando diferentes disciplinas económicas para complementar la perspectiva de la innovación organizativa. El estudio está basado en los datos de la encuesta CIS de España e incluye 16.843 firmas que respondieron haber introducido cualquier tipo de resultado innovador en sectores manufactureros y de servicios (a partir de una encuesta de 33.363 empresas). En general, los resultados subrayan el hecho de que la actividad de innovación de proceso en contextos de media y baja tecnología, es explicada principalmente por los esfuerzos no-I+D, mostrando una baja dependencia del suministro externo de inputs, por ejemplo fuentes externas de conocimiento, el tamaño no es importante y los recursos internos pueden sustituir a los externos, con un enfoque más interno de la generación de conocimiento. La tesis presenta también importantes implicaciones para los políticos, sobre todo frente a los problemas de selectividad de la muestra usualmente observados en la mayoría de estudios de innovación de proceso. / Boronat Moll, C. (2012). ANÁLISIS DE LA INNOVACIÓN EN PROCESO Y ESTUDIO DE LOS NON-R&D INNOVATORS. EVIDENCIA EMPÍRICA PARA ESPAÑA [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/19210

Yes / Technologies can help strengthen the resilience of our economy against existential climate-risks. We investigate climate change adaptation technologies (CCATs) in US patents to understand (1) historical patterns and possible drivers of innovation; (2) scientific and technological requirements to develop and use CCATs; and (3) CCATs’ potential technological synergies with mitigation. First, in contrast to mitigation, innovation in CCATs only slowly takes off, indicating a relatively low awareness of investors for solutions to cope with climate risks. We discuss how historical trends in environmental regulation, energy prices, and public support may have contributed to patenting in CCATs. Second, CCATs form two main clusters: science-intensive ones in agriculture, health, and monitoring technologies; and engineering-intensive ones in coastal, water, and infrastructure technologies. Analyses of technology-specific scientific and technological knowledge bases inform directions for how to facilitate advancement, transfer and use of CCATs. Lastly, CCATs show strong technological complementarities with mitigation as more than 25% of CCATs bear mitigation benefits. While not judging about the complementarity of mitigation and adaptation in general, our results suggest how policymakers can harness these technological synergies to achieve both goals simultaneously.

京都大学 / 新制・課程博士 / 博士(経済学) / 甲第25079号 / 経博第686号 / 新制||経||306(附属図書館) / 京都大学大学院経済学研究科経済学専攻 / (主査)教授 神事 直人, 准教授 高野 久紀, 教授 森 知也 / 学位規則第4条第1項該当 / Doctor of Agricultural Science / Kyoto University / DGAM

知識經濟時代與全球化潮流下，創新是廠商提升自我競爭力的重要途徑。創新乃原始概念到將知識商業化的一連串過程，而過去探討廠商創新的研究取向多元，研究觀點則以經濟地理學、企業管理學為主，綜合相關研究，大致可將影響廠商創新的因素歸類為三大面向：廠商內部屬性、對外網絡連結關係、廠商所處地區的環境條件。其中，創新氛圍乃是特定地區的行動者透過偕同作用及集體學習過程所產生的社會關係，提升了地區的創新能力，同時提供有利於廠商創新的環境條件，是近來區域發展的重要議題。本研究即綜合上述三大面向因素來探討廠商創新活動(研發投入與研發合作)與創新成效之影響因素。 創新氛圍理論從早期”某種東西之地方化”的探討，演變到後期關注於地方生產系統的運作是受到地區創新氛圍的影響所致；其中，創新氛圍量化指標的缺乏、探討領域的侷限，乃是本研究所要突破之處。本研究以工業區分佈情形、自然與人文界線、通勤圈範圍等原則，先將台灣地區分為46個地區分析單元，再參酌地方生產系統概念，以兩個指標：LQ大於1與製造業就業員工數大於50000人，篩選出26個地區作為研究範圍，最後以科技與傳統產業LQ大於1指標，區別出9個科技產業群聚地區、17個傳統產業群聚地區，藉以比較不同產業領域、地區發展程度不同之創新氛圍。準此，本研究以8個創新氛圍的相關指標，經過因素分析後萃取出2個創新氛圍因素：「創新綜效」、「創新成效」；藉此將台灣46個地區劃分為4種創新氛圍類型：創新氛圍、有創新無氛圍、有氛圍與創新、無創新無氛圍。 於廠商創新活動與成效實證分析方面，本研究採取兩個階段進行，分別皆以三個面向因素(廠商內部屬性、研發合作、地區創新氛圍)的影響因素來探討廠商創新活動與成效之差異。針對創新氛圍方面，於第一階段以不同產業群聚地區的虛擬變數作為隱含地區創新氛圍的概念，測試其對廠商創新活動與成效的影響，第二階段則以地區創新氛圍因素(創新綜效、創新成效)進行科技與傳統產業群聚地區的廠商創新成效之測試。整體研究結果顯示，科技產業群聚地區的廠商傾向自身的研發投入，而傳統產業群聚地區的廠商則多以研發合作居多，但科技產業群聚地區的廠商創新成效較佳；地區創新氛圍確實對於廠商的創新活動與成效有顯著的影響，尤其對於科技產業群聚地區的廠商創新成效更有顯著的貢獻；而研發合作對於廠商創新成效的影響則不如預期。因此，從基礎產業發展環境、知識設施的聚集、地區網絡的建構等方面，來促使各地區創新氛圍之形塑，將有利於地區廠商的創新，特別應加強傳統產業群聚地區的創新氛圍；此外，提倡廠商強化內部基本體質亦是促進廠商創新效率之關鍵所在。 / Under the wind of the knowledge-based economics and globalization, innovation is an important way for firms to increase their own competitiveness. Innovation is the process from original concept to business. The past researches on firm innovation branch widely, most focus on economic geography and corporation management. From those related researches, we can simplify the elements which can influence the innovation of the firm into three: firms’ inner attributes, relation of the connection to outside network, and the environment of the area which firms located. Innovation milieu is the social relationship which actors in the area could make it happen through interactions and group learning, which can advance the area’s innovation ability, and give the good environment condition for firms to innovate. Innovative milieu is the important issue in the present regional development researches, this research will integrate the three elements to discuss the influence on firms innovation activities and innovation success. The theory of the innovative milieu have transformed from discussion of “the localization of something” to focus on the relation of the work of the regional production system and the local innovative milieu. But, the lack of the quantification indicator, and the territory of the research field still need to break through, and is the focus of this research. This research divide Taiwan into 46 analysis area unit, then bring into the concept of the local production system, use two indicators to choose 26 elements as the scope of the research, and farther define 26 analysis area unit into 9 technology industry cluster area, and 17 traditional industry cluster area, to compare the differences of the industry field and the level of the development of the innovation milieu. This research take 8 innovative milieu related indexes, and compress into 2 indexes: “innovation synergy” and “innovation success” through the content analysis; this research use these two indexes to divide 46 areas of Taiwan into 4 types of innovation milieu: innovative milieu, no innovative milieu, innovation but without milieu, and milieu but without innovation. On the analysis of the firms’ innovation activities and the success, this research take two steps to discuss. At the first step, this research use the dummy variables of the different industry cluster area as the concept of the regional innovative milieu, to check the influence it could make on the firms innovation activities and the success; At the second step, this research use regional innovative milieu indexes to check the firms’ innovation success of the traditional and technology industry cluster area. The whole research shows that the firms of technology industry aggregation area are tend to invest on their own R&D, which the firms of traditional industry aggregation area often do their R&D by cooperating with others, and the innovation outcome of firms of the technology industry aggregation area is better. The regional innovative milieu has the conspicuous influence on the firms innovation activities and the success, especially to the technology industry cluster area, but the influence which the R&D cooperation could make on the innovation outcome is not good as expect. Thus, the making of the basic environment of the industry development, the aggregation of the knowledge facilities, and the build of the local network is the good impact for local firms to innovate, especially for the traditional industry aggregation area ones. At the same time, to reinforce the firms’ inner constitution is also the key to promote the firms innovation.

La thèse a pour but d’étudier la possibilité et la faisabilité économique de démarches de diversification des produits et d’amélioration des caractéristiques qualitatives des aliments par les entreprises, dans un contexte dans lequel ces modifications sont soumises à des contraintes techniques induisent des coûts non négligeables, non nécessairement valorisés par le marché. Dans ce cadre, nous cherchons à comprendre dans quelle mesure il est possible pour les autorités publiques d’intervenir pour inciter les entreprises à consentir des efforts suffisants (en termes d’investissement en amont) de façon à favoriser la mise en marché de produits conformes à la qualité voulue par la société. Nous avons appliqué ces perspectives de recherches à deux problématiques sociétales importantes et d’actualité, à savoir la coexistence des filières OGM et non OGM et la question de la santé et de la nutrition à travers l’enjeu de l’entrée de gammes de produits plus acceptables d’un point de vue nutritionnel (moins de sucre, de gras, …). Ces problématiques qui occupent les deux parties de la thèse sont élaborées en mobilisant des outils de la Théorie de l’Organisation Industrielle. Les résultats montrent que les choix spontanés de gammes de produits par les firmes ne sont pas toujours socialement satisfaisant, ce qui implique dans certaines conditions une intervention publique. Dans le cas de la coexistence OGM/non-OGM, le produit non-OGM peut ne pas avoir la caractéristique souhaitée en absence de régulation. Pour ce qui est des enjeux nutritionnels, les firmes présentes sur le marché n’offrent pas systématiquement des aliments favorables sur le plan de la santé en l’absence d’intervention publique. La thèse aboutit à la conclusion générale qu’il est souvent nécessaire de combiner plusieurs instruments publics. Dans le cas de la coexistence OGM/non-OGM, les pouvoirs publics peuvent gérer de manière efficace la coexistence en agissant simultanément sur le seuil d’étiquetage, les conditions de réalisation des tests et contrôles et le niveau de la pénalité. Dans le cas de la question nutritionnelle, l’intervention par le biais d’une subvention à la R&D présente certaines faiblesses telles que le risque d’instrumentalisation de la subvention par la firme ou induit des distorsions au détriment de la santé publique. Ceci suggère de combiner la subvention à la R&D avec un autre instrument tel que la taxation. / Our research aims at analyzing the economic feasibility of approaches for product diversification and quality characteristics improvement by firms, in a context where these modifications are subject to technical constraints that induce high costs not necessarily valued by the market. In this context, we try to understand how it is possible for public authorities to intervene in order to encourage firms to make sufficient efforts (in terms of upstream investment) and facilitate the marketing of products in response to the needs of society. We apply these research perspectives to two important issues, namely the GM/non-GM coexistence and the health and nutrition issue through the development of product lines which are more acceptable from a nutritional point of view (for example, less sugar, fat, salt…). These two research issues are developed by mobilizing the tools of the Theory of Industrial Organization. The results show that the spontaneous choice of product lines by firms is not always socially satisfactory, which implies that in certain conditions, public intervention is desirable. In the case of GM/non-GM coexistence, non-GM products may not have the desired characteristics in the absence of regulation. In terms of health issues, companies in the market do not offer high nutritional value foods in the absence of public intervention. Overall, this thesis concludes that it is often necessary to combine several public instruments. In the first study, we show that the public authorities can effectively manage the GM/non-GM coexistence by acting simultaneously through the labelling threshold definition, the quality tests and controls, and the level of the penalty cost in case of non compliance. In the second study, we show that an intervention through Research and Development (R&D) subsidies has some weaknesses such as the risk of manipulation of the grant by firms, or the possibility of triggering distortions to the detriment of public health. This suggests combining the R&D subsidies with another instrument such as taxation

Cette thèse présente trois chapitres qui mobilisent un cadre d’analyse évolutionniste et qui étudient empiriquement la relation « innovation-performance » à partir de données CIS. Nous souhaitons montrer que les sources de l’innovation et les méthodes d’appropriation varient en fonction des secteurs d’activité et des stratégies d’innovation des firmes. Dans un premier temps, nous décrivons les tendances de l’innovation à partir de quatre vagues d’enquêtes CIS (1994-2006) et nous analysons la persistance de l’innovation sur un échantillon de 431 firmes avec une régression logistique binaire. Nous montrons que la persistance de l’innovation est plus élevée pour les firmes qui innovent en produits car ces firmes sont contraintes d’investir de manière continue dans des projets d’innovation pour rester compétitives. Les firmes qui innovent en procédés sont moins persistantes car leur stratégie est plus orientée vers des ajustements de la qualité des produits ainsi que vers l’amélioration des processus de production. Les deux derniers essais explorent avec la méthode des doubles moindres carrés le lien innovation-performance économique sur un échantillon de 7 742 firmes portant sur la période 2002-2005. Nous expliquons que la source principale de l’innovation des firmes à « forte intensité scientifique » est la R&D, d’une part, et que les méthodes d’appropriation des rentes de l’innovation passent par l’acquisition d’actifs complémentaires (tels que l’utilisation combinée de titres de propriété intellectuelle et de secrets de fabrication), d’autre part. En revanche, les firmes dans les autres catégories (notamment celles à fortes économies d’échelle) fondent leurs avancées technologiques sur des sources externes de l’innovation telles que les concurrents, les fournisseurs et les utilisateurs avancés. De plus, ces firmes utilisent de manière plus importante des méthodes d’appropriation commerciale telles que les marques ou les stratégies marketing, car leurs produits sont moins exposés au risque d’imitation certes, mais aussi parce qu’elles sont sensibles aux changements de coûts. / This thesis is structured in three essays based on evolutionary theoretical grounds and provides empirical evidence from CIS. It aims at showing that the sources of innovation and the appropriation of innovation rents vary in function of firms’ activities and innovation strategies.In essay 1, we describe four waves of CIS, covering the period 1994-2006 and we study persistent innovation behavior with a discrete choice model on a data set of 431 firms. We find that innovation persistence is more important for product innovators because they need novel products to be more competitive and therefore enrich their base of knowledge continuously. By contrast, process innovators are less persistent because innovation strategy is less “market” oriented and intends to meet quality or production adjustments. The two last essays explore with the two stage least squares method how firms benefit economically from their innovations on a sample of 7 742 firms, on the period 2002-2005. We show that science-based firms rely more on R&D investments to develop their products and maintain their leads by acquiring complementary assets, i.e. they use mixed methods to appropriate the rents of innovation (the combined use IPRs and strategic methods for instance secrecy). By contrast, firms in other categories (for instance firms using cost-cutting strategies) draw more on external sources of knowledge coming either from suppliers or advanced users. Additionally, these firms use more extensively trademarks or non technological methods of appropriation (as marketing devices), because they are less exposed to potential imitation and because they are price sensitive.

O consenso entre os organismos internacionais de cooperação para o comércio e para o desenvolvimento econômico está em reconhecer na capacidade de inovar a principal fonte para a promoção da produtividade nas organizações. Parte do esforço brasileiro de construção e desenvolvimento de um sistema nacional de inovação constituiu-se na criação de programas de incentivos fiscais, como forma de fazer avançar os investimentos em Pesquisa, Desenvolvimento & Inovação - P&D&I, provocando o setor privado a participar mais intensamente do processo de financiamento do desenvolvimento tecnológico. Uma década após a implementação do principal programa de incentivo fiscal à inovação no Brasil (Lei nº 11.196/05), é mister verificar se tais incentivos foram capazes de atingir os seus objetivos. A presente tese visa a avaliar: (i) qual a repercussão sobre os dispêndios com P&D&I da opção pela utilização dos incentivos fiscais concedidos pela Lei do Bem e (ii) quanto da renúncia fiscal, ou seja, dos créditos recebidos pelas empresas participantes deste programa, retornou em termos de investimentos em P&D&I ao longo do tempo. A metodologia empregada, propõe a estimação de um modelo empírico para os dispêndios em P&D&I, em que estes são explicados ora pela opção da empresa por utilizar os incentivos fiscais da Lei do Bem ora pela renúncia fiscal decorrente da utilização do mesmo programa, além de um conjunto de variáveis de controle associado às restrições de financiamento. Os testes estatísticos foram conduzidos para o agregado das companhias de capital aberto, registradas na BM&FBOVESPA em 2013, relativamente a seus desempenhos no período de 2008 a 2013. Os resultados, para dados em painel dinâmico, foram obtidos a partir do modelo GMM-System e apontam que a decisão de utilizar os incentivos fiscais da Lei do Bem está associada a um aumento nos dispêndios com P&D&I, ao longo do tempo. Assim sendo, para cada ponto percentual de aumento na propensão das companhias em optar pelo uso da Lei do Bem espera-se de 0,65 a 0,85 pontos percentuais de aumento em seus dispêndios com P&D&I. Por outro lado, o aumento de um ponto percentual na renúncia fiscal gera uma expectativa de aumento nos dispêndios com P&D&I das companhias, que pode variar de 0,26 a 0,40 pontos percentuais, ao longo do tempo / The consensus among international cooperation agencies for trade and economic development lies in recognizing in the ability to innovate the main source for promoting productivity in organizations. The Brazilian effort of construction and development of a national innovation system constituted the creation of tax incentive programs as a way to advance investments in Research, Development & Innovation - R&D&I, causing the private sector to participate more intensely financing process of technological development. A decade after the implementation of major tax incentive program for innovation in Brazil (Law nº. 11.196/05), it is necessary to verify that such incentives were able to achieve their goals. The present thesis aims at evaluating: (i) the impact on R&D&I expenditures of the option to use the tax incentives granted by the \"Lei do Bem\" and (ii) how much of tax waiver, that is to say, of the credits received by companies participating in this program, has returned in terms of R&D&I investments over time. The methodology to be used proposes the estimation of an empirical model for R&D&I expenditure, which are explained either by the company\'s option to use tax incentives of the \"Lei do Bem\" or by tax credits obtained due to the use of tax incentives program, in addition to a set of control variables associated with financing constraints. The statistical tests were conducted to the group of publicly traded companies listed on the BM & FBOVESPA in 2013, for their performances in the period 2008 to 2013. The results for the dynamic panel data were obtained from the GMM-System model and indicate that the decision to use the \"Lei do Bem\" tax incentives is associated with an increase in R&D&I expenditures over time. So that for each percentage point of increase in the propensity of companies to opt for the use of the \"Lei do Bem\", 0.65 to 0.85 percentage points of increase in R&D&I expenditures is expected. On the other hand, the increase of one percentage point in the tax waiver generates an expectation of increase in the R&D&I expenses of the companies, which can vary from 0.26 to 0.40 percentage points, over time

O modelo de promoção da inovação em saúde predominante na atualidade é baseado na proteção da propriedade intelectual por meio da concessão de patentes. A patente permite ao seu titular explorar o objeto protegido com exclusividade por um determinado período de tempo, no qual seria obtido o retorno do investimento feito na pesquisa e desenvolvimento do produto. A obtenção de retorno do custo da P&D pela comercialização do produto final, potencializada pelo monopólio conferido pela patente, faz com o que o detentor da tecnologia estabeleça preço de venda elevado. O sistema de patentes potencializa, assim, a maximização de lucros das empresas farmacêuticas, ampliando seu interesse no desenvolvimento de produtos rentáveis e na mercantilização da saúde. Foram identificadas e sistematizadas evidências que demonstram que a aplicação do sistema de patente na área da saúde tem gerado problemas de inovação, ao direcionar recursos de P&D voltados para a produção de produtos rentáveis e não voltados a atender necessidades de saúde; e de acesso, uma vez que o preço elevado excluí milhões de pessoas do consumo do produto. Ficou demonstrada a necessidade de busca de medidas para superação desses problemas. Identificou-se medidas existentes dentro do sistema de patentes que poderiam ser utilizadas para minimizar os problemas identificados em curto e médio prazo, com uma abordagem caso a caso. Optou-se por utilizar uma abordagem sistêmica, demonstrando a necessidade de medidas alternativas ao sistema de patentes para resolução dos problemas identificados a longo prazo. A identificação de medidas alternativas foi realizada por meio da revisão de mais de uma centena de propostas enviadas em chamada aberta e recomendações feitas por diferentes órgãos da Organização Mundial de Saúde no período de 2003 a 2012. As medidas identificadas foram descritas, sistematizadas e analisadas. Conclui-se que a principal proposta atualmente em discussão é a criação de um Fundo Global de P&D, no marco de uma Convenção Global de P&D em saúde, que financiaria a P&D mediante a concessão de prêmios, e não de patentes. Os resultados da P&D seriam tratados como bens públicos, e poderiam ser produzidos por qualquer interessado. Esse modelo visa desvincular os custos da P&D do preço final do produto. Com isso, tem o potencial de solucionar os problemas de inovação e acesso à saúde identificados no sistema de patentes. No entanto, enfrenta grande oposição dos defensores do sistema de patentes, principalmente grandes empresas farmacêuticas interessadas na ampliação da mercantilização da saúde. / The model for promoting innovation in health prevalent nowadays is based on the protection of intellectual property by granting patents. The patent allows the holder to exploit the protected object with exclusivity for a certain period of time, in which he could obtain the return of investment made in research and development. The need to obtain the return of the investments made on R&D by selling the final product, boosted by the monopoly conferred by the patent, allows the patent holder to establish high price. The patent system maximizes profits of pharmaceutical companies, expanding its interest in developing profitable products and in health commodification. We identified and systematized evidence to show that the application of the patent system in the health sector has generated innovation problems, by directing R&D resources to the production of profitable products and not driven by health needs; and access, since the high price excludes millions of product consumption. It was demonstrated the need for seeking measures to overcome these problems. We identified existing measures within the patent system that could be used to alleviate the problems identified in the short and medium term, with a case-by-case approach. We chose to use a systemic approach, demonstrating the need for alternative measures to the patent system to resolve the problems identified in the long-term. The identification of alternative measures was conducted through review of more than a hundred proposals submitted in open call and recommendations made by different bodies of the World Health Organization from 2003 to 2012. The measures identified have been described, systematized and analyzed. It is concluded that the main proposal currently under discussion is the creation of a Global R&D Fund, as part of a Global R&D Convention on health, which would finance R&D by granting prizes, and not patents. The results of R&D would be treated as public goods, and could be produced by any interested party. This model aims to delink the costs of R&D from the final price of the product. Thus, it has the potential to solve the problems of innovation and access to health identified in the patent system. However, it faces strong opposition from advocates of the patent system, especially large pharmaceutical companies interested in expanding health commodification.

Made available in DSpace on 2016-04-26T20:52:37Z (GMT). No. of bitstreams: 1 Fernando dos Santos Lima.pdf: 2138394 bytes, checksum: c6115ce77580968d577f6fee48f9388f (MD5) Previous issue date: 2015-03-04 / National innovative capacity (NIC) is the ability of a country to create and trade a flow of technological innovation for a long period of time given the strength of the internal infrastructure of innovation, the environment for innovation in key industrial clusters and the interaction between these two areas. The objective of this dissertation is to validate conclusions about convergence obtained by Stern, Porter and Furman (2000), taking into account the changes occurred in the last 20 years. In order to reach our goal, based on the NIC theory, we developed an empiric exploration of the R&D productivity determinants and international patents production and a group of observables characteristics associated to NIC. The results we found direct us to conclude that a convergence process has intensified in the last 20 years, however there are relevant differences in the growth patent production between developed and emerging countries / Capacidade nacional de inovação (CNI) é a habilidade de um país de produzir e comercializar um fluxo de inovação tecnológica por um longo período dado a força da infraestrutura de inovação interna, o ambiente para inovação nos principais clusters industriais e a interligação entre essas duas áreas. O objetivo deste trabalho de pesquisa é revalidar conclusões sobre convergência obtidas por Stern, Porter e Furman (2000), levando em consideração as mudanças ocorridas nos últimos 20 anos. Para atingir esse objetivo, com base no arcabouço teórico da CNI, desenvolvemos uma exploração empírica dos determinantes de nível de produtividade nacional de P&D e da relação entre a produção de patentes internacionais e um conjunto de características observáveis associadas à CNI. Os resultados que encontramos apontam que um processo de convergência se intensificou nos últimos 20 anos, existindo diferenças marcantes nos determinantes para o crescimento da produção de patentes entre países desenvolvidos e em crescimento